ARCHIVES

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

This article is from The Cancer Letter archive.

Vol. 36 No. 44 | December 3, 2010

Download PDF Visit The Full Archive

Related Articles

Phase III PANORAMA-1 Trial Meets PFS Primary Endpoint

June 27, 2014

Funding Opportunities: NIH Creates Awards For Clinical Research

March 27, 1998

NCA Urges Switching More Funds To Grants From Contract Programs Over Entire Three Years

July 2, 1976

DCT Board Okays New Surgery RFA, Will Hear Request For Support Of 30 Surgical Centers

April 11, 1980

FDA Tightens Conflict of Interest Rules For Advisors.

March 23, 2007

Avastin For Adjuvant Treatment Of Colon Cancer Showed Benefit At One Year, But Failed Overall

June 5, 2009